Evidence map›Paper›PMID 38802904›Full record

ArticleZhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics2024

[Application of metagenomic next-generation sequencing technology in preterm infants with sepsis following antibiotic use].

Chun-Yan Lou, Yu-Ning Liu, Xuan Zhang, Yan-Yan Guo, Lei Zhang

Abstract readEnglish Abstract
In one paragraph

Article in Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Chun-Yan LouDepartment of Neonatology, Henan Provincial People's Hospital/Zhengzhou University People's Hospital, Zhengzhou 450003, China.
Yu-Ning LiuDepartment of Neonatology, Henan Provincial People's Hospital/Zhengzhou University People's Hospital, Zhengzhou 450003, China.
Xuan ZhangDepartment of Neonatology, Henan Provincial People's Hospital/Zhengzhou University People's Hospital, Zhengzhou 450003, China.
Yan-Yan GuoDepartment of Neonatology, Henan Provincial People's Hospital/Zhengzhou University People's Hospital, Zhengzhou 450003, China.
Lei ZhangDepartment of Neonatology, Henan Provincial People's Hospital/Zhengzhou University People's Hospital, Zhengzhou 450003, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo explore the value of metagenomic next-generation sequencing (mNGS) technology in the etiological diagnosis of sepsis in preterm infants following antibiotic use.

methodsA retrospective analysis of medical records for 45 preterm infants with sepsis who were treated at Henan Provincial People's Hospital. All patients received antibiotic treatment for ≥3 days and underwent both blood culture and mNGS testing. The detection rates of pathogens by blood culture and mNGS testing were compared.

resultsThe positive detection rate of pathogens by blood mNGS was higher than that by blood culture (44% vs 4%;

conclusionsIn preterm infants with sepsis following antibiotic use, the positive rate of pathogen detection by blood mNGS is higher than that by blood culture and is unaffected by the duration of antibiotic use. Therefore, mNGS testing can be considered for confirming pathogens when clinical suspicion of infection is high but blood culture fails to detect the pathogen.

Indexed as

Anti-Bacterial AgentsHigh-Throughput Nucleotide SequencingInfant, PrematureMetagenomicsSepsisFemaleHumansInfant, NewbornMaleRetrospective StudiesAnti-Bacterial AgentsAntibioticBlood cultureMetagenomic next-generation sequencing technologyPreterm infantSepsis

Identifiers

PMID38802904
PMCPMC11135064

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.